Hardback : $244.00
Drug Law Reform in East and Southeast Asia is a multi-author look at drugs in East and Southeast Asia, on drug policy, patterns and trends, local problems, human rights abuses, treatment prospects, and potential reforms. From the history of drugs in Asia, the book examines recent trends in illicit drugs, especially the present enormous amphetamine problems. It addresses recent policy shifts, especially harm reduction responses to the devastating drug-associated HIV epidemics. It explores further necessary reform, especially in regard to the abysmally inhuman current emphasis on detention and the death penalty for drug offences, and present the most recent evidence on effective and humane approaches to drug treatments. As the first comprehensive collection on illicit drug and harm reduction in East and Southeast Asia, it will be a vital resource for health professionals, policymakers, and others working there—and elsewhere—on drug policy reform. As the first comprehensive collection on illicit drugs and harm reduction in East and Southeast Asia, it will be a vital resource for health professionals, policymakers, and others working on East and Southeast Asia—and elsewhere—on drug policy.
Drug Law Reform in East and Southeast Asia is a multi-author look at drugs in East and Southeast Asia, on drug policy, patterns and trends, local problems, human rights abuses, treatment prospects, and potential reforms. From the history of drugs in Asia, the book examines recent trends in illicit drugs, especially the present enormous amphetamine problems. It addresses recent policy shifts, especially harm reduction responses to the devastating drug-associated HIV epidemics. It explores further necessary reform, especially in regard to the abysmally inhuman current emphasis on detention and the death penalty for drug offences, and present the most recent evidence on effective and humane approaches to drug treatments. As the first comprehensive collection on illicit drug and harm reduction in East and Southeast Asia, it will be a vital resource for health professionals, policymakers, and others working there—and elsewhere—on drug policy reform. As the first comprehensive collection on illicit drugs and harm reduction in East and Southeast Asia, it will be a vital resource for health professionals, policymakers, and others working on East and Southeast Asia—and elsewhere—on drug policy.
Foreword
Introduction
Chapter 3: Historical Perspectives of Drug Use in Asia
Chapter 4: Harm Reduction is Good Public Health
Chapter 5: Human Rights and Drug Policy
Chapter 6: Drug Users and Imprisonment
Chapter 7: Law Enforcement and Drug Policy in Southeast Asia
Chapter 8: Effective Development and Effective Drug Control are
Interdependent: the example of Southeast Asia
Chapter 9: Illicit drug policy in Southeast Asia – The Users’
Perspective
Chapter 10: Harm Reduction: The Islamic Perspective
Chapter 11: HIV and Hepatitis C Virus (HCV) Infection among People
who Inject Drugs in East and Southeast Asia
Chapter 12: Unpacking Compulsory ‘Rehabilitation’ in Asia: Problems
and Possible Solutions
Chapter 13: Responding to ATS use in East and Southeast Asia
Chapter 14: Case Study No. 1: Harm Reduction and Drug Policy in
Thailand – One Step Forward, Two Steps Back
Chapter 15: Case Study No. 2: Drug Policy in Taiwan
Chapter 16: Case Study No. 3: Emerging from a Black Box: Drug
Policymaking in Vietnam
Chapter 17: Case Study No. 4: Drug Policy in China
Chapter 18: Case Study No. 5: Compulsory Drug Rehabilitation in
China
Chapter 19: Alternatives to Criminal Justice: Drug Courts, Drug
Diversion, and Decriminalisation
Chapter 20: Capital Punishment for Drug Offences
Chapter 21: Drug Treatment Across Asia
Chapter 22: The Way Forward
Fifa Rahman is policy manager at the Malaysian AIDS Council.
Nick Crofts is director of the Centre for Law Enforcement and
Public Health.
Punitive drug policies have done enormous harm to drug users and
their neighbors all over the world. These policies have been
particularly vicious in some parts of East and Southeast Asia. This
has resulted in massive HIV and hepatitis epidemics in many
countries. Fifa Rahman and Nick Croft’s Drug Law Reform in East and
Southeast Asia is a wonderfully insightful overview of these
policies and their effects—as well as presenting alternative
policies and evidence that these alternative policies do much less
damage than punitive approaches. They do this by presenting a range
of articles by leading professionals, a chapter on drug user
activists’ perspectives on drug policy, and a chapter on Islamic
approaches. All in all, this is a useful and lovely book.
*Sam Friedman, Institute of Infectious Disease Research*
This expansive volume successfully combines expert analysis with
policy recommendations to provide a timely and much-needed overview
of drug markets and policy responses in East and Southeast Asia. It
is a must-read for anyone wanting to understand the complexities of
drug policy in a region where shifts in attitude have taken place
but where further drug law reform remains overdue.
*David Bewley-Taylor, Swansea University*
A timely and comprehensive review of drug policy issues which moves
beyond ideology and calls for a complete reexamination of existing
practices in the Asia region. The authors provide clear guidance as
to why existing policies have failed based on detailed case studies
of key countries, and propose a new approach to drugs that is based
on human rights within a framework of public health. Essential
reading for anyone interested in drug policy issues and how best to
respond.
*Desmond Cohen, Former Director of UNDP's HIV and Development
Programme*
![]() |
Ask a Question About this Product More... |
![]() |